UNSPSC 51162302: Acetaminophen/aluminum acetate/chlorpheniramine/phenylpropanolam

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162302 Acetaminophen/aluminum acetate/chlorpheniramine/phenylpropanolam is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though recent opportunities show divergence from the code's nominal scope. The Washington State Department of Corrections (DOC) solicitation RFQQK13020 for parenteral products, services, and equipment targets intravenous solutions, parenteral nutrition (TPN and PPN), and controlled substances for incarcerated individuals across eight correctional facilities, with delivery requirements of 24 hours for PN bags and 8 hours for other parenteral products. A separate Seminole County, Florida procurement (IFB60459723LAS) sought naloxone and drug deactivation systems for community health initiatives. The issuing bodies include state departments of corrections and county health authorities, reflecting the code's application to institutional healthcare procurement rather than retail pharmacy or consumer pharmaceutical distribution.

Recent activity concentrates in Washington state and Florida, with the Washington DOC procurement representing the more substantial engagement—DOC anticipates selecting up to three contractors per region across West, Central, and East zones, with an initial contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the first two years. The Washington DOC RFQ closed October 7, 2026, and included set-aside aspirations (small business 25%, minority-owned 10%, women-owned 6%, veteran-owned 5%) under Chapter 39.19 RCW. Contractors must maintain Commercial General Liability ($1 million per occurrence / $2 million aggregate), Professional Liability ($2 million per occurrence / aggregate), Business Automobile Liability ($1 million per occurrence / $2 million aggregate), and Cyber Liability ($2 million per occurrence / aggregate). The Seminole County opportunity, posted June 30, 2026 with a due date of July 26, 2023, appears to contain a date inconsistency in the source and specified annual volumes of 1,900 units of naloxone and 800 drug deactivation systems with quarterly deliveries. Overall, the code shows limited recent activity and significant scope divergence from its pharmaceutical product name, warranting verification that opportunities are being tagged to the correct commodity classification.